Terashima, M., Ichikawa, W., Ochiai, A., Kitada, K., Kurahashi, I., Sakuramoto, S., . . . Sasako, M. (2017). TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study. Oncotarget.
シカゴスタイル引用形Terashima, Masanori, et al. "TOP2A, GGH, and PECAM1 Are Associated With Hematogenous, Lymph Node, and Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Enrolled in the ACTS-GC Study." Oncotarget 2017.
MLA引用形式Terashima, Masanori, et al. "TOP2A, GGH, and PECAM1 Are Associated With Hematogenous, Lymph Node, and Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Enrolled in the ACTS-GC Study." Oncotarget 2017.